Graziani G - Search Results

1

Minotti G, Graziani G, Delogu G. Minotti G, et al. Among authors: graziani g. Chemotherapy. 2016;61(1):1-2. doi: 10.1159/000441664. Epub 2015 Nov 3. Chemotherapy. 2016. PMID: 26523523 Free article. No abstract available.

2

On the Horizon: Targeting Next-Generation Immune Checkpoints for Cancer Treatment.

Tundo GR, Sbardella D, Lacal PM, Graziani G, Marini S. Tundo GR, et al. Among authors: graziani g. Chemotherapy. 2019;64(2):62-80. doi: 10.1159/000500902. Epub 2019 Aug 6. Chemotherapy. 2019. PMID: 31387102 Free article. Review.

3

Beneficial and Detrimental Effects of Antiretroviral Therapy on HIV-Associated Immunosenescence.

Franzese O, Barbaccia ML, Bonmassar E, Graziani G. Franzese O, et al. Among authors: graziani g. Chemotherapy. 2018 Mar 13;63(2):64-75. doi: 10.1159/000487534. Online ahead of print. Chemotherapy. 2018. PMID: 29533947

4

Effects of Glutathione Transferase-Targeting Nitrobenzoxadiazole Compounds in Relation to PD-L1 Status in Human Melanoma Cells.

Sciarretta F, Fulci C, Palumbo C, Rotili D, Tentori L, Graziani G, Caccuri AM. Sciarretta F, et al. Among authors: graziani g. Chemotherapy. 2019;64(3):138-145. doi: 10.1159/000503339. Epub 2019 Oct 22. Chemotherapy. 2019. PMID: 31639786 Free article.

5

Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors.

Lacal PM, Graziani G. Lacal PM, et al. Among authors: graziani g. Pharmacol Res. 2018 Oct;136:97-107. doi: 10.1016/j.phrs.2018.08.023. Epub 2018 Aug 28. Pharmacol Res. 2018. PMID: 30170190 Review.

6

At the Cutting Edge against Cancer: A Perspective on Immunoproteasome and Immune Checkpoints Modulation as a Potential Therapeutic Intervention.

Tundo GR, Sbardella D, Oddone F, Kudriaeva AA, Lacal PM, Belogurov AA Jr, Graziani G, Marini S. Tundo GR, et al. Among authors: graziani g. Cancers (Basel). 2021 Sep 28;13(19):4852. doi: 10.3390/cancers13194852. Cancers (Basel). 2021. PMID: 34638337 Free PMC article. Review.

7

MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.

Tentori L, Muzi A, Dorio AS, Dolci S, Campolo F, Vernole P, Lacal PM, Praz F, Graziani G. Tentori L, et al. Among authors: graziani g. Cancer Chemother Pharmacol. 2013 Jul;72(1):117-25. doi: 10.1007/s00280-013-2175-0. Epub 2013 May 1. Cancer Chemother Pharmacol. 2013. PMID: 23636450

8

Challenging resistance mechanisms to therapies for metastatic melanoma.

Tentori L, Lacal PM, Graziani G. Tentori L, et al. Among authors: graziani g. Trends Pharmacol Sci. 2013 Dec;34(12):656-66. doi: 10.1016/j.tips.2013.10.003. Epub 2013 Nov 7. Trends Pharmacol Sci. 2013. PMID: 24210882 Review.

9

Neuropilin-1 as Therapeutic Target for Malignant Melanoma.

Graziani G, Lacal PM. Graziani G, et al. Front Oncol. 2015 Jun 3;5:125. doi: 10.3389/fonc.2015.00125. eCollection 2015. Front Oncol. 2015. PMID: 26090340 Free PMC article. Review.

10

Targeting Tumor-Associated Macrophages to Increase the Efficacy of Immune Checkpoint Inhibitors: A Glimpse into Novel Therapeutic Approaches for Metastatic Melanoma.

Ceci C, Atzori MG, Lacal PM, Graziani G. Ceci C, et al. Among authors: graziani g. Cancers (Basel). 2020 Nov 17;12(11):3401. doi: 10.3390/cancers12113401. Cancers (Basel). 2020. PMID: 33212945 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

794 results

Search Page